ATE191712T1 - Neue strukturelle vitamin d derivate - Google Patents

Neue strukturelle vitamin d derivate

Info

Publication number: ATE191712T1
Authority: AT; Austria
Prior art keywords: vitamin; ring; derivatives; analogue; membered
Prior art date: 1993-07-09

Application number

AT94924749T

Other languages

English (en)

Inventor

Roger Bouillon

Maurits Vandewalle

Clercq Pierre Jean De

Original Assignee

Theramex

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-09

Filing date

1994-07-07

Publication date

2000-04-15

1994-07-07 Application filed by Theramex filed Critical Theramex

2000-04-15 Application granted granted Critical

2000-04-15 Publication of ATE191712T1 publication Critical patent/ATE191712T1/de

Links

150000003710 vitamin D derivatives Chemical class 0.000 title abstract 6
229930003316 Vitamin D Natural products 0.000 abstract 5
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 5
235000019166 vitamin D Nutrition 0.000 abstract 5
239000011710 vitamin D Substances 0.000 abstract 5
229940046008 vitamin d Drugs 0.000 abstract 5
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/27—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing six carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/19—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups
- C07C47/192—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/28—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/36—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/28—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/37—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/242—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/385—Saturated compounds containing a keto group being part of a ring
- C07C49/517—Saturated compounds containing a keto group being part of a ring containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT94924749T 1993-07-09 1994-07-07 Neue strukturelle vitamin d derivate ATE191712T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP93202037		1993-07-09
PCT/EP1994/002294 WO1995001960A1 (en)	1993-07-09	1994-07-07	Novel structural analogues of vitamin d

Publications (1)

Publication Number	Publication Date
ATE191712T1 true ATE191712T1 (de)	2000-04-15

Family

ID=8213977

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT94924749T ATE191712T1 (de)	1993-07-09	1994-07-07	Neue strukturelle vitamin d derivate
AT99203513T ATE251133T1 (de)	1993-07-09	1994-07-07	Neue strukturelle vitamin d derivate

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT99203513T ATE251133T1 (de)	1993-07-09	1994-07-07	Neue strukturelle vitamin d derivate

Country Status (16)

Country	Link
US (2)	US6017907A (de)
EP (2)	EP0972762B1 (de)
JP (2)	JP4235256B2 (de)
CN (1)	CN1103755C (de)
AT (2)	ATE191712T1 (de)
AU (1)	AU699200B2 (de)
CA (1)	CA2166898C (de)
DE (2)	DE69433220T2 (de)
DK (2)	DK0707566T3 (de)
ES (2)	ES2209327T3 (de)
GR (1)	GR3033856T3 (de)
NO (1)	NO314142B1 (de)
NZ (1)	NZ271332A (de)
PT (2)	PT707566E (de)
RU (1)	RU2153491C2 (de)
WO (1)	WO1995001960A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE191712T1 (de) *	1993-07-09	2000-04-15	Theramex	Neue strukturelle vitamin d derivate
BR9509739A (pt) *	1994-11-21	1997-10-21	Wisconsin Alumni Res Found	Compostos 18,19-dinor-vitamina d
US5661140A (en) *	1994-11-21	1997-08-26	Wisconsin Alumni Research Foundation	18-nor-vitamin D compounds
DE69606680T2 (de) *	1995-10-30	2000-08-17	F. Hoffmann-La Roche Ag, Basel	1-Alpha, 26-dihydroxy-D-homo-vitamin D3
CN1201452A (zh) *	1995-10-31	1998-12-09	弗·哈夫曼-拉罗切有限公司	24－高－26,27－六氟－胆钙化甾醇
US5716946A (en) *	1996-02-13	1998-02-10	Wisconsin Alumni Research Foundation	Multiple sclerosis treatment
DE19619036A1 (de)	1996-04-30	1997-11-13	Schering Ag	Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP0983221B1 (de) *	1997-05-23	2002-04-03	Basilea Pharmaceutica AG	Cyclohexandiolderivate
AUPO727097A0 (en)	1997-06-10	1997-07-03	Unisearch Limited	Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU735676B2 (en) *	1997-06-10	2001-07-12	Mrc Holdings Pty Limited	Method of treatment of liver tumours and pharmaceutical compositions for use therein
WO1999012894A1 (en) *	1997-09-08	1999-03-18	F. Hoffmann-La Roche Ag	1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
US5919986A (en) *	1997-10-17	1999-07-06	Hoffmann-La Roche Inc.	D-homo vitamin D3 derivatives
DE69939106D1 (de) *	1998-02-24	2008-08-28	Chugai Pharmaceutical Co Ltd	Verfahren zur Herstellung von ED-71
US6184422B1 (en) *	1998-02-26	2001-02-06	Hoffman-La Roche Inc.	Cyclohexanediol derivatives
WO1999049870A1 (en) *	1998-03-27	1999-10-07	Oregon Health Sciences University	Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
US5962707A (en) *	1998-08-18	1999-10-05	Wisconsin Alumni Research Foundation	19-nor-vitamin D3 compounds with calcemic activity
US6479474B2 (en)	1999-07-08	2002-11-12	Wisconsin Alumni Research Foundation	Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
DE19935771A1 (de) *	1999-07-23	2001-02-01	Schering Ag	Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6310262B1 (en) *	1999-10-18	2001-10-30	Basilea Pharmaceutica Ag	Process for preparing retiferol derivatives
EP1106618A1 (de)	1999-12-08	2001-06-13	Laboratoire Theramex	Vorläuferverbindungen für den A-Ring von Vitamin-D, Verfahren zur Herstellung und Zwischenprodukte dazu
KR100732271B1 (ko)	1999-12-08	2007-06-25	라보라뚜와르 떼라멕스	비타민 디 전구체, 제조방법 및 중간체
US7632518B2 (en) *	2002-01-15	2009-12-15	Dsm Ip Assets B.V.	25-hydroxy vitamin D3 compositions
GB0305332D0 (en) *	2003-03-10	2003-04-09	Leuven K U Res & Dev	Biological evaluation of novel vitamin D analogues
WO2004110380A2 (en) *	2003-06-11	2004-12-23	Novacea, Inc.	Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
US20050074443A1 (en) *	2003-10-03	2005-04-07	Treadwell Benjamin V.	Methods of attenuating autoimmune disease and compositions useful therefor
GB0422929D0 (en) *	2004-10-15	2004-11-17	Leuven K U Res & Dev	Bioactive vitamin D analogues
US7713951B2 (en) *	2004-04-09	2010-05-11	Wisconsin Alumni Research Foundation	2-alkylidene-18,19-dinor-vitamin D compounds
GB0423091D0 (en) *	2004-10-19	2004-11-17	Leuven K U Res & Dev	Bioactive vitamin d analogues
US20080069814A1 (en) *	2005-01-05	2008-03-20	Novacea, Inc.	Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
AU2006239883A1 (en) *	2005-04-22	2006-11-02	Novacea, Inc.	Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
AU2009206449B2 (en) *	2008-01-22	2014-04-24	Wisconsin Alumni Research Foundation	13,13-Dimethyl-des-C,D analogs of 1alpha, 25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions
US8109466B2 (en) *	2008-06-23	2012-02-07	Rohr, Inc.	Thrust reverser cascade assembly and AFT cascade ring with flow deflector portion
AU2010208323B2 (en)	2009-01-27	2016-03-10	Berg Llc	Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
NZ596497A (en) *	2009-05-20	2013-05-31	Hybrigenics Sa	New therapeutical uses of inecalcitol
EP2464357B1 (de)	2009-08-14	2019-05-22	Berg LLC	Vitamin d3 und analoge davon zur behandlung von alopezie
PT2360145E (pt) *	2010-01-26	2012-06-27	Hybrigenics Sa	Novo processo para isomerização de estruturas bicíclicas condensadas e preparação de análogos de vitamina d que as contêm
EP2572204B1 (de)	2010-05-20	2017-12-27	Roche Diagnostics GmbH	Freisetzungsreagens für vitamin d-verbindungen
CA2805198C (en)	2010-07-15	2018-07-31	Hybrigenics Sa	New formulations of 14-epi-analogues of vitamin d and cmc
US20120015913A1 (en)	2010-07-15	2012-01-19	Delansorne Remi	Formulations of 14-EPI-Analogues of Vitamin D
EP2407152A1 (de)	2010-07-15	2012-01-18	Hybrigenics S.A.	Formulierungen von 14-epi-Analoga von Vitamin D
EP3467510B1 (de)	2011-11-18	2022-10-26	F. Hoffmann-La Roche AG	Freisetzungsreagens für vitamin-d-verbindungen
CA2857385A1 (en)	2011-11-30	2013-06-06	Alphora Research Inc.	Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9174956B2 (en)	2011-12-16	2015-11-03	Alphora Research Inc.	Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
JP6300030B2 (ja)	2011-12-29	2018-03-28	サンドアクツィエンゲゼルシャフト	２−（（２ｓ，３ｓ，４ｒ，５ｒ）−５−（（ｓ）−３−アミノ−２−ヒドロキシプロプ−１−イル）−４−メトキシ−３−（フェニルスルホニルメチル）テトラヒドロフラン−２−イル）アセトアルデヒド誘導体およびこれらを調製するためのプロセス
US9278979B2 (en)	2012-03-30	2016-03-08	Alphora Research Inc.	Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
BR112015022577A2 (pt)	2013-03-14	2017-07-18	Aquinox Pharmaceuticals Canada Inc	moduladores ship1 e métodos relacionados a esse
EP2970122B1 (de)	2013-03-14	2019-05-08	Aquinox Pharmaceuticals (Canada) Inc.	Ship1-modulatoren
SG10201709894RA (en)	2013-05-29	2018-01-30	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
GB2515128B (en)	2013-06-10	2015-05-27	Givaudan Sa	Improvements in or relating to organic compounds
US9682914B2 (en)	2014-01-13	2017-06-20	P2 Science, Inc.	Terpene-derived acids and esters and methods for preparing and using same
WO2015196019A1 (en)	2014-06-20	2015-12-23	P2 Science, Inc.	Film ozonolysis in a tubular or multitubular reactor
US20170247314A1 (en) *	2014-08-06	2017-08-31	P2 Science, Inc.	Fragrances from the esters of fatty acids
GB201421855D0 (en) *	2014-12-09	2015-01-21	Givaudan Sa	Improvements in or relating to organic compounds
US9944590B2 (en)	2015-06-26	2018-04-17	Aquinox Pharmaceuticals (Canada) Inc.	Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en)	2016-01-20	2017-07-27	Aquinox Pharmaceuticals (Canada) Inc.	Synthesis of a substituted indene derivative
CA3026192A1 (en)	2016-06-21	2017-12-28	P2 Science, Inc.	Flow-through reactors for the continuous quenching of peroxide mixtures and methods comprising the same
US10696605B2 (en)	2016-09-16	2020-06-30	P2 Science, Inc.	Uses of vanadium to oxidize aldehydes and ozonides
EP3866968A4 (de)	2018-10-19	2022-07-27	P2 Science, Inc.	Neue verfahren zur disproportionierungsabschreckungvon ozoniden
CN110330522A (zh) *	2019-07-29	2019-10-15	南京海融医药科技股份有限公司	一种帕立骨化醇异构体杂质py5的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61501146A (ja) *	1984-01-30	1986-06-12	ウイスコンシン　アラムナイ　リサ−チ　フォンデ−ション	側鎖不飽和１−ヒドロキシビタミンｄ化合物
NZ232734A (en) *	1989-03-09	1991-11-26	Wisconsin Alumni Res Found	19-nor vitamin d derivatives and pharmaceutical compositions
CA1333616C (en) *	1989-03-09	1994-12-20	Hector F. Deluca	19-nor-vitamin d compounds
DE3913310A1 (de) *	1989-04-20	1990-10-25	Schering Ag	Spirocyclopropane in der vitamin d-reihe
AU650751B2 (en) *	1991-05-28	1994-06-30	Wisconsin Alumni Research Foundation	Novel synthesis of 19-nor vitamin D compounds
AU666563B2 (en) *	1992-08-07	1996-02-15	Wisconsin Alumni Research Foundation	Preparation of 19-nor-vitamin D compounds
IL107185A (en) *	1992-10-06	1998-02-22	Schering Ag	Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
ATE191712T1 (de) *	1993-07-09	2000-04-15	Theramex	Neue strukturelle vitamin d derivate

1994
- 1994-07-07 AT AT94924749T patent/ATE191712T1/de active
- 1994-07-07 AT AT99203513T patent/ATE251133T1/de active
- 1994-07-07 DE DE69433220T patent/DE69433220T2/de not_active Expired - Lifetime
- 1994-07-07 EP EP99203513A patent/EP0972762B1/de not_active Expired - Lifetime
- 1994-07-07 DE DE69423966T patent/DE69423966T2/de not_active Expired - Lifetime
- 1994-07-07 CA CA002166898A patent/CA2166898C/en not_active Expired - Lifetime
- 1994-07-07 DK DK94924749T patent/DK0707566T3/da active
- 1994-07-07 PT PT94924749T patent/PT707566E/pt unknown
- 1994-07-07 PT PT99203513T patent/PT972762E/pt unknown
- 1994-07-07 WO PCT/EP1994/002294 patent/WO1995001960A1/en not_active Ceased
- 1994-07-07 ES ES99203513T patent/ES2209327T3/es not_active Expired - Lifetime
- 1994-07-07 RU RU96104272/04A patent/RU2153491C2/ru active
- 1994-07-07 DK DK99203513T patent/DK0972762T3/da active
- 1994-07-07 CN CN94193323A patent/CN1103755C/zh not_active Expired - Lifetime
- 1994-07-07 ES ES94924749T patent/ES2147238T3/es not_active Expired - Lifetime
- 1994-07-07 JP JP50383595A patent/JP4235256B2/ja not_active Expired - Lifetime
- 1994-07-07 US US08/571,887 patent/US6017907A/en not_active Expired - Lifetime
- 1994-07-07 AU AU74927/94A patent/AU699200B2/en not_active Expired
- 1994-07-07 NZ NZ271332A patent/NZ271332A/en not_active IP Right Cessation
- 1994-07-07 EP EP94924749A patent/EP0707566B1/de not_active Expired - Lifetime
1996
- 1996-01-09 NO NO19960099A patent/NO314142B1/no not_active IP Right Cessation
1999
- 1999-10-28 US US09/428,927 patent/US6548715B1/en not_active Expired - Fee Related
2000
- 2000-06-30 GR GR20000401558T patent/GR3033856T3/el unknown
2005
- 2005-09-01 JP JP2005253297A patent/JP4312183B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69423966T2 (de)	2000-11-16
ES2147238T3 (es)	2000-09-01
PT972762E (pt)	2004-02-27
DE69433220D1 (de)	2003-11-06
DE69423966D1 (de)	2000-05-18
JPH09500117A (ja)	1997-01-07
US6017907A (en)	2000-01-25
AU7492794A (en)	1995-02-06
WO1995001960A1 (en)	1995-01-19
EP0972762A2 (de)	2000-01-19
DK0707566T3 (da)	2000-09-04
CA2166898A1 (en)	1995-01-19
JP4312183B2 (ja)	2009-08-12
CA2166898C (en)	2004-09-07
JP2006001944A (ja)	2006-01-05
NO314142B1 (no)	2003-02-03
GR3033856T3 (en)	2000-10-31
ES2209327T3 (es)	2004-06-16
NO960099L (no)	1996-03-08
NZ271332A (en)	2001-03-30
DE69433220T2 (de)	2004-08-19
ATE251133T1 (de)	2003-10-15
EP0707566B1 (de)	2000-04-12
CN1130899A (zh)	1996-09-11
EP0707566A1 (de)	1996-04-24
CN1103755C (zh)	2003-03-26
RU2153491C2 (ru)	2000-07-27
DK0972762T3 (da)	2004-02-09
EP0972762B1 (de)	2003-10-01
AU699200B2 (en)	1998-11-26
US6548715B1 (en)	2003-04-15
NO960099D0 (no)	1996-01-09
JP4235256B2 (ja)	2009-03-11
EP0972762A3 (de)	2000-02-23
PT707566E (pt)	2000-09-29

Legal Events

Date	Code	Title	Description
2000-09-15	UEP	Publication of translation of european patent specification
2007-09-15	EEIH	Change in the person of patent owner

Publication	Publication Date	Title
ATE251133T1 (de)	2003-10-15	Neue strukturelle vitamin d derivate
ITMI920528A1 (it)	1993-09-06	14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
DE69223914D1 (de)	1998-02-12	4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
DE59102210D1 (de)	1994-08-25	Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES2070628T3 (es)	1995-06-01	Uso de compuestos analogos a 1,3-oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
ES2147739T3 (es)	2000-10-01	Fosfonooximetil-eteres de derivados de taxano.
IL97025A0 (en)	1992-03-29	17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
ATE79538T1 (de)	1992-09-15	Dispergierbare zubereitung.
IL93500A0 (en)	1990-11-29	11-beta-substituted-19-nor steroids,their preparation and pharmaceutical compositions containing them
GR1000723B (el)	1992-11-23	Aντιστροφος ατροφια του δερματος η οποια προκαλειται απο γλυκοκορτικοειδη
DK0441279T3 (da)	1995-05-08	Bilobalid-phospholipid-komplekser, deres anvendelse og sammensætninger, der indeholder dem
NO902710L (no)	1990-12-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater.
PT1078627E (pt)	2006-10-31	Formulacao farmaceutica compreendendo amoxicilina e clavulanato
IT8721691A0 (it)	1987-08-21	Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
IT1241079B (it)	1993-12-29	Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
IT8721687A0 (it)	1987-08-21	Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
NZ246598A (en)	1997-08-22	Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
NO172491C (no)	1993-07-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
ITMI911845A1 (it)	1993-01-04	Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
MX9307009A (es)	1995-01-31	Derivados de 5-[(imidaol{4,5-b}piridin-3-il]metil/benzofurano, procesopara su preparacion y composiciones farmaceuticas que los contienen.
MX9303392A (es)	1994-06-30	Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
HUP0301334A2 (hu)	2003-08-28	Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
LU81501A1 (fr)	1979-10-31	Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
ATE74505T1 (de)	1992-04-15	Schmerzpraeparat.
ATE224401T1 (de)	2002-10-15	Thiocolchicosid-derivate, ihre herstellung und verwendung als arzneimittel